Mutual Funds - Profile

Saratoga Health & Biotechnology Portfolio

US > Health/Biotechnology >

Rank

Universe Rank
58 2

Summary

The fund seeks capital appreciation in the long term by investing in companies across any size in the United States.

The investment process is designed to highlight companies that are engaged in the healthcare and biotechnology industries.

The investment team emphasizes companies engaged in: the design, manufacture or sale of products or services used for or in connection with health, medical, or personal care such as medical, dental and optical supplies or equipment; research and development of pharmaceutical products and services.

Other companies that the team focuses on are involved in the operation More

Price

  • Last Close
  • $23.63
    -0.46
  • 52 Week HL
  • $25.32 - $21.21
  • Net Assets
  • $13.49 M
  • Expense Ratio

Portfolio

  • Holdings
  • -
  • Turnover Ratio
  • -

Sector Allocation
Mar 31, 2021

Top 10 Holdings
Mar 31, 2021

Company Holding
McKesson Corp. 5.75
Charles River 5.21
United Therapeutics 4.92
Amgen Inc 4.92
Medtronic PLC 4.79
Company Holding
Total 25.59%

Manager

  • Name
  • Robert D. Stimpson
  • Leadership
  • Single Manager
  • Tenure
  • 2003
  • Advisor

Documents

  • Prospectus
  • Annual Reports

Performance
-1.1 % YTD

  • 3 Year
  • 2.93%
  • 5 Year
  • 20.63%
  • Best
  • 37%
    2009
  • Worst
  • -20.96%
    2008

Returns +
A

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
SBHIX 0%29%16%29%-6%19%8%-1%14%29%13%
S&P 500 -2%27%16%29%-6%19%10%-1%11%30%13%

Returns +
Q

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Q1 -1.1% 4.6% -12.4% 3.9% -5.3% 6.9% -3.3% 7.4% 7.2% 12.2% -
Q2 - 6.8% 9.9% -1.2% 5.4% 6% 6.8% -0.6% 2.7% 3.3% -
Q3 - -1.6% 0.5% -0.7% 10.9% -2.3% - -6.9% 1% 6.3% -
Q4 - 2.2% -4.2% 8.8% -13.2% 0.4% -4.7% 8% 8.5% 10.6% -

Returns +
M

J F M A M J J A S O N D
2022 -1.1% - - - - - - - - - - -
2021 1.1% -1.2% 4.7% 4.4% -0.4% 2.8% 2.6% 1.7% -5.7% 2.5% -4.7% 4.6%

Annual
Return

Index Comparison

Alpha

NAV